NO20014081L - Anvendelse av tianeptin i produksjonen av medikamenter til behandling av nevrodegenerative patologier - Google Patents

Anvendelse av tianeptin i produksjonen av medikamenter til behandling av nevrodegenerative patologier

Info

Publication number
NO20014081L
NO20014081L NO20014081A NO20014081A NO20014081L NO 20014081 L NO20014081 L NO 20014081L NO 20014081 A NO20014081 A NO 20014081A NO 20014081 A NO20014081 A NO 20014081A NO 20014081 L NO20014081 L NO 20014081L
Authority
NO
Norway
Prior art keywords
manufacture
tianeptin
drugs
treat neurodegenerative
neurodegenerative pathologies
Prior art date
Application number
NO20014081A
Other languages
English (en)
Other versions
NO20014081D0 (no
Inventor
Antoine Deslandes
Michael Spedding
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20014081L publication Critical patent/NO20014081L/no
Publication of NO20014081D0 publication Critical patent/NO20014081D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Psychiatry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • AIDS & HIV (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Oppfinnelsen vedrører anvendelsen av tianeptin eller enantiomerer derav i fremstillingen av medikamenter som anvendes for å behandle nevrodegenerative patologier.
NO20014081A 1999-04-07 2001-08-22 Anvendelse av tianeptin i produksjonen av medikamenter til behandling av nevrodegenerative patologier NO20014081D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9904313A FR2791891A1 (fr) 1999-04-07 1999-04-07 Utilisation de la tianeptine pour l'obtention de medicaments destines au traitement des pathologies de la neurodegenerescence
PCT/FR2000/000865 WO2000059511A1 (fr) 1999-04-07 2000-04-06 Utilisation de la tianeptine pour l'obtention de medicaments destines au traitement des pathologies de la neurodegenerescence

Publications (2)

Publication Number Publication Date
NO20014081L true NO20014081L (no) 2001-08-22
NO20014081D0 NO20014081D0 (no) 2001-08-22

Family

ID=9544103

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014081A NO20014081D0 (no) 1999-04-07 2001-08-22 Anvendelse av tianeptin i produksjonen av medikamenter til behandling av nevrodegenerative patologier

Country Status (17)

Country Link
US (1) US6599896B1 (no)
EP (1) EP1165089A1 (no)
JP (1) JP2002541110A (no)
KR (1) KR20010102463A (no)
CN (1) CN1342082A (no)
AU (1) AU3824800A (no)
BR (1) BR0008703A (no)
CA (1) CA2361988A1 (no)
EA (1) EA200100802A1 (no)
FR (1) FR2791891A1 (no)
HK (1) HK1042053A1 (no)
HU (1) HUP0200145A3 (no)
NO (1) NO20014081D0 (no)
NZ (1) NZ513565A (no)
PL (1) PL356739A1 (no)
WO (1) WO2000059511A1 (no)
ZA (1) ZA200106690B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
JP2007532559A (ja) * 2004-04-08 2007-11-15 ヴェラ アクイジション コーポレイション 神経因性疼痛、線維筋痛および慢性疲労症候群の治療のための組成物および方法
EP1752143A1 (en) * 2005-08-08 2007-02-14 NewThera Novel uses for drugs targeting glutamine synthetase
US9314469B2 (en) * 2008-05-05 2016-04-19 Tonix Pharma Holdings Limited Method for treating neurocognitive dysfunction
JO2844B1 (en) * 2008-10-31 2014-09-15 ترانسفورم فارماسيتيكالز، انك.‏ Forms of Tyapentin sulfate salt and methods of its manufacture and use
US8198268B2 (en) 2008-10-31 2012-06-12 Janssen Biotech, Inc. Tianeptine sulfate salt forms and methods of making and using the same
KR20120092993A (ko) * 2011-02-14 2012-08-22 지엘팜텍 주식회사 티아넵틴 또는 이의 약제학적으로 허용되는 염을 포함하는 경구투여용 서방성 정제
KR101136976B1 (ko) * 2011-09-06 2012-05-30 건일제약 주식회사 티아넵틴 또는 그의 염을 포함하는 탈모증의 예방 또는 치료용 약학 조성물
BR112019013244A2 (pt) 2016-12-28 2019-12-24 Tonix Pharma Holdings Ltd sais e polimorfos de oxalato de tianeptina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2635461B1 (fr) * 1988-08-18 1992-01-17 Adir Utilisation de derives tricycliques pour l'obtention de medicaments destines au traitement du stress
FR2716623B1 (fr) * 1994-02-25 1996-08-23 Adir Utilisation d'un dérivé tricyclique pour l'obtention de médicaments destinés au traitement des troubles mnémo-cognitifs.
FR2747921B1 (fr) * 1996-04-24 1998-10-30 Adir Comprime matriciel permettant la liberation prolongee du sel de sodium de tianeptine apres administration par voie orale

Also Published As

Publication number Publication date
HUP0200145A2 (hu) 2002-05-29
US6599896B1 (en) 2003-07-29
CN1342082A (zh) 2002-03-27
NZ513565A (en) 2004-04-30
BR0008703A (pt) 2002-02-13
JP2002541110A (ja) 2002-12-03
HUP0200145A3 (en) 2004-07-28
EP1165089A1 (fr) 2002-01-02
CA2361988A1 (fr) 2000-10-12
PL356739A1 (en) 2004-06-28
WO2000059511A1 (fr) 2000-10-12
FR2791891A1 (fr) 2000-10-13
KR20010102463A (ko) 2001-11-15
AU3824800A (en) 2000-10-23
EA200100802A1 (ru) 2002-04-25
HK1042053A1 (zh) 2002-08-02
ZA200106690B (en) 2002-11-14
NO20014081D0 (no) 2001-08-22

Similar Documents

Publication Publication Date Title
UY28931A1 (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
TR200200768T2 (tr) Yeni kuinüklidin türevleri ve bunu içeren ilaç bileşimleri
TR200103575T2 (tr) Sülfonamid ve sülfamid ikameli/katkılı imidazokinolinler
MA26548A1 (fr) Compositions pharmaceutiques topiques contenant des derives de resorcinol.
NO965516L (no) Sterolderivater anvendt til regulering av meiose
ATE408601T1 (de) Fredericamycin-derivate
NO20045323L (no) Antistoffer
ATE231872T1 (de) Thiazolopyrimidinderivate
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
PT1176963E (pt) Utilizacao de ligandos do receptor d3 da dopamina no fabrico de medicamentos para o tratamento de disturbios da funcao renal
TNSN06012A1 (en) Emulsifying systems containing azetidine derivatives
ME00578A (en) Use of gastrointestinal lipase inhibitors
DK1001761T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsunderskudslidelser
AU2924699A (en) Tryptase inhibitors
NO20014081L (no) Anvendelse av tianeptin i produksjonen av medikamenter til behandling av nevrodegenerative patologier
SE9801494D0 (sv) Novel use
ATE286894T1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
NO975028L (no) Piperazinoderivater som neurokininantagonister
ATE266029T1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
IS2849B (is) Notkun á írbesartani til framleiðslunnar á lyfjum sem eru notuð til að fyrirbyggja eða meðhöndla lungnaháþrýsting
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
NO20020914D0 (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
NO20001894D0 (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application